G01N 2333/4739
Cyclin
Official title: Cyclin; Prad 1
G01N2333/4739 (Cyclin) appears on 48 US grants and 98 published applications in this corpus.
Search patents in G01N- Granted patents
- 48
- Published applications
- 98
- Assignees
- 52
- Inventors
- 207
- Latest grant
- 24 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 7 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 5 |
| 2003 | 1 | 14 |
| 2004 | 1 | 3 |
| 2005 | 2 | 5 |
| 2006 | 1 | 6 |
| 2007 | 2 | 6 |
| 2008 | 2 | 7 |
| 2009 | 3 | 4 |
| 2010 | 1 | 4 |
| 2011 | 1 | 6 |
| 2012 | 5 | 1 |
| 2013 | 1 | 2 |
| 2014 | 2 | 4 |
| 2015 | 1 | 6 |
| 2016 | 3 | 5 |
| 2017 | 2 | 3 |
| 2018 | 1 | 2 |
| 2019 | 0 | 1 |
| 2020 | 0 | 3 |
| 2021 | 2 | 2 |
| 2022 | 2 | 2 |
| 2023 | 2 | 1 |
| 2024 | 1 | 3 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cyclin G1 inhibitors and related methods of treating cancer24 Dec 2024US 12,173,041 B2Delta Next-Gene, LLC
- Multiple myeloma treatment29 Aug 2023US 11,737,993 B2Vanda Pharmaceuticals Inc.
- Prediction of response to immune-modulatory therapies9 May 2023US 11,644,467 B2Yale University
- Methods to predict progression of Barrett's Esophagus to high grade dysplasia esophageal adenocarcinoma19 Jul 2022US 11,391,737 B2United Kingdom Research and Innovation
- Cyclin G1 inhibitors and related methods of treating cancer10 May 2022US 11,325,958 B2Delta Next-Gene, LLC
- Combination therapy for cancer21 May 2026US 2026/0137711 A1National University of Ireland, Galway
- Use of cyclin e1 status as a predictive biomarker for treating cancer with wee1 inhibitors21 Aug 2025US 2025/0262215 A1Zeno Management, Inc.
- Cyclin-dependent kinase 2 inhibitors for medical treatment19 Jun 2025US 2025/0199015 A1Incyclix Bio, LLC
- Wee1 inhibitors and methods for treating cancer12 Dec 2024US 2024/0408097 A1
- Multiple myeloma treatment17 Oct 2024US 2024/0342120 A1Vanda Pharmaceuticals Inc.
Most cited
By later US patents
- Diagnostic panel of cancer antibodies and methods for use77US 8,216,789 B2University of Washington · 2012
- Cell-cycle regulatory proteins, and uses related thereto25US 5,962,316 ACold Spring Harbor Laboratory · 1999
- Cell cycle regulatory protein p16 gene22US 5,889,169 ACold Spring Harbor Laboratory · 1999
- Cell-cycle regulatory proteins, and uses related thereto10US 6,043,030 ACold Spring Harbor Laboratory · 2000
- Method for detecting carcinomas in a solubilized cervical body sample10US 7,306,926 B2MTM Laboratories, AG · 2007